Goodman Group (ASX:GMG) and this ASX 200 blue chip share could be in the buy zone right now. Here’s why brokers rate them highly…
The post 2 brilliant blue chip ASX 200 shares brokers love appeared first on The Motley Fool Australia. –
If you’re wanting to construct a balanced portfolio, owning a few blue chip ASX 200 shares could be a smart move.
But which blue chip ASX 200 shares should you buy? Two that could be in the buy zone are listed below:
Goodman Group (ASX: GMG)
The first blue chip ASX 200 share to consider is Goodman Group. It is a global property group that owns, develops and manages industrial real estate including logistics and industrial facilities, warehouses, and business parks.
It focuses on high-quality properties in key locations that will benefit its customers now, and in the future, and to deliver sustainable returns for investors.
This strategy has been working wonders. Goodman has been growing at a consistently strong rate over the last decade and looks well-positioned to continue this trend for some time to come. Particularly given its current portfolio and burgeoning development pipeline.
In fact, Macquarie recently suggested that Goodman could achieve double digit earnings growth through until at least FY 2024. As a result, the broker has put an outperform rating and $20.39 price target on its shares.
ResMed Inc. (ASX: RMD)
Another blue chip ASX 200 share to look at is ResMed. It is a leading medical device company with a focus on sleep disorders.
ResMed has a portfolio of industry-leading products and cloud-based solutions that have significant market opportunities. This is being underpinned by the growing awareness of sleep disorders and particularly sleep apnoea.
The company is also well-placed to benefit from the shift to home healthcare thanks to its investments in out-of-hospital platforms in recent years.
Analysts at Credit Suisse are positive on ResMed. They believe the company can also achieve double-digit earnings growth over the medium term. The broker currently has an outperform rating and $29.50 price target on its shares.
Where to invest $1,000 right now
When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*
Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.
*Returns as of February 15th 2021
- The latest 3 ASX shares leading brokers are urging you to buy now
- 3 fantastic ASX shares to buy this month
- Leading brokers name 3 ASX shares to buy today
- 3 of the best ASX shares to buy this month
- 3 ASX shares to buy for the real estate explosion
Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has recommended ResMed Inc. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.